Physician profile
David C Tingler
NPI 1124235478
$5,689.12
in general payments reported to CMS, 2019-2025
19 companies · $57.50 in 2025
The $57.50 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,277 · 2020: $506 · 2021: $730 · 2022: $734 · 2023: $774 · 2024: $611 · 2025: $57.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,593.61 | 2019-2024 | Gallant, Jot Dx, Amplatzer Amulet |
| Janssen Pharmaceuticals, INC | $913.38 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $721.97 | 2019-2023 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $583.00 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $477.52 | 2019-2024 | Wainua, Farxiga, Brilinta |
| Amgen INC. | $228.25 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.13 | 2019-2025 | Lifevest |
| Pfizer INC. | $210.64 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.72 | 2019-2023 | Jardiance |
| Cvrx, INC. | $113.66 | 2021 | |
| Boston Scientific Corporation | $98.84 | 2019-2022 | |
| Zoll Respicardia, INC. | $92.99 | 2023-2024 | Remede System |
| Sanofi-Aventis U.S. LLC | $81.89 | 2019-2020 | |
| Gilead Sciences, INC. | $67.78 | 2019 | |
| Merck Sharp & Dohme LLC | $50.45 | 2022-2024 | Verquvo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $34.75 | 2019 | |
| Amarin Pharma, INC. | $33.60 | 2019-2020 | |
| Stryker Corporation | $23.54 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lantheus Medical Imaging, INC. | $16.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tingler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.